rivastigmine has been researched along with enbucrilate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, KP; Paramakrishnan, N; Samanta, MK; Santhi, K; Suresh, B; Wilson, B | 1 |
| Chavhan, SS; Joshi, SA; Sawant, KK | 1 |
2 other study(ies) available for rivastigmine and enbucrilate
| Article | Year |
|---|---|
Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Delivery Systems; Enbucrilate; Male; Nanoparticles; Phenylcarbamates; Polysorbates; Rats; Rats, Wistar; Rivastigmine; Surface-Active Agents; Up-Regulation | 2008 |
Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.
Topics: Amnesia; Animals; Biological Transport; Brain; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Enbucrilate; Lactic Acid; Maze Learning; Mice; Nanoparticles; Neuroprotective Agents; Particle Size; Phenylcarbamates; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rivastigmine; Scopolamine | 2010 |